Article

On the Web: Integrative Therapy for Cancer Care

Conducting online research can be overwhelming. CURE makes it quick & easy by providing links to the best information from organizations we trust.

Conducting online research can be overwhelming. CURE makes it quick & easy by providing links to the best information from organizations we trust.

American Cancer Society

cancer.org/treatment/TreatmentsAndSideEffects/ComplementaryAndAlternativeMedicine/index

American Society of Clinical Oncology

cancer.net/navigating-cancer-care/how-cancer-treated/complementary-and-alternative-medicine-cam

Memorial Sloan Kettering Cancer Center

mskcc.org/cancer-care/integrative-medicine

MD Anderson Cancer Center

mdanderson.org/CIMER

National Cancer Institute

cancer.gov/cancertopics/cam

National Center for Complementary and Alternative Medicine

nccam.nih.gov

U.S. Food and Drug Administration

www.fda.gov/food/DietarySupplements/default.htm

Complementary and Alternative Medicine — Mayo Clinic

mayoclinic.org/healthy-living/ consumer-health/in-depth/alternative-medicine/art-20045267?footprints=mine

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of man.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Related Content
Illustration of blood cells.
May 1st 2025

In Vivo CD19 CAR-T Leads to Remission in DLBCL Without Lymphodepletion

Ryan Scott
A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following novel in vivo CD19 CAR-T therapy.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
LUT014 improved rashes in patients with colorectal cancer undergoing anti-EGFR therapy: © stock.adobe.com.
May 1st 2025

BRAF Inhibitor Gel Improves Acne-Like Skin Rashes in Colorectal Cancer

Spencer Feldman
LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, according to UCLA researchers.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Image of bladder.
April 30th 2025

Aidixi Plus Bacillus Calmette-Guérin Effective in Bladder Cancer

Jason M Broderick
Aidixi plus BCG showed strong early efficacy and manageable safety in patients with high-risk, HER2-expressing non–muscle-invasive bladder cancer.
Illustration of woman with blonde hair.
April 30th 2025

Lingering Stress After Follicular Lymphoma Remission is a Challenge

Karen Cohn
Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue to weigh heavily on me.